Latest News about MRK
Recent news which mentions MRK
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
October 22, 2021
From Motley Fool
Bristol Myers Pledges To Offload Acceleron Shares: Bloomberg
October 21, 2021
From Benzinga
2 COVID Stocks I'd Consider Instead of Moderna
October 21, 2021
From Motley Fool
PDS Biotech Pauses Recruitment In PDS0101 Combo Cancer Trial
October 21, 2021
From Benzinga
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
From Benzinga
From Benzinga
It’s Time to Secure Those Profits You Earned from Novavax
October 20, 2021
From InvestorPlace
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
From Benzinga
Here's Why Moderna's Growth May Be Just Getting Started
October 20, 2021
From Motley Fool
Why Atea Pharmaceuticals Is Imploding Today
October 19, 2021
From Motley Fool
David v Goliath in The Race to Develop an Oral Therapy for COVID-19
October 19, 2021
From Benzinga
WHO-Led Program Intends To Purchase Oral COVID-19 Antivirals For $10, Including Merck's: Reuters
October 19, 2021
Tickers
MRK
From Benzinga
2 Best Biotech Stocks to Buy Right Now
October 18, 2021
From Motley Fool
2 Bargain Stocks You Can Buy Today and Hold Forever
October 18, 2021
From Motley Fool
3 Stocks to Consider if the October Stock Market Sell-Off Worsens
October 17, 2021
From Motley Fool
Here's Why Warren Buffett Isn't Buying Many Stocks Right Now
October 17, 2021
From Motley Fool
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
From Motley Fool
3 COVID-19 Pill Stocks to Watch
October 16, 2021
From Motley Fool
Better COVID-19 Stock: Merck or Pfizer?
October 16, 2021
From Motley Fool
From Benzinga
The success of Merck’s antiviral—and other COVID-19 pills in development—may depend on how quickly people start taking them
October 14, 2021
From MarketWatch
7 Biotech Penny Stocks With Huge Catalysts Coming in 2022
October 14, 2021
Tags
NASDAQ:BLU,NASDAQ:ENTX,OTCMKTS:CYDY,OTCMKTS:ATRX,NASDAQ:DFFN,OTCMKTS:HALB,OTCMKTS:TSOI,NYSE:MRK
BLU
HALB
From InvestorPlace
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
October 14, 2021
From Benzinga
Why Novavax Stock Is Absurdly Cheap Right Now
October 14, 2021
From Motley Fool
Novavax Stock Fortunes Are Still Awaiting the Magical Headline
October 13, 2021
From InvestorPlace
3 Biotech Stocks You Can Buy and Hold for the Next Decade
October 13, 2021
From Motley Fool
2 Reasons to Buy Novavax Stock Now and 1 Reason to Skip It
October 13, 2021
From Motley Fool
This development may fully reopen the global economy — and the stock market has mostly ignored it
October 13, 2021
From MarketWatch
Can Carnival Stock Buck the Delta Variant and Gain Traction?
October 13, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.